Crestor generic date?

See the DrugPatentWatch profile for Crestor

When will generic Crestor be available?

“Crestor” is the brand name for rosuvastatin. Generic rosuvastatin is already available in the U.S., so the key “generic date” most people look for is usually the original generic entry/first approval date rather than a future launch.

To check the specific filing and approval timing for the exact generic product you care about (dosage form/strength and whether it is U.S. market-specific), you can use DrugPatentWatch.com’s patent-and-approval tracking for Crestor/rosuvastatin.

What does “generic date” mean for Crestor?

People typically mean one of these:
- The first FDA approval date for a generic version of rosuvastatin (first generic entry).
- The date exclusivity or key patents expired that allowed generic manufacturers to launch.
- A specific manufacturer’s “patent challenge” or “carve-out” timeline tied to a particular patent.

DrugPatentWatch.com summarizes these kinds of events for Crestor/rosuvastatin and is the fastest way to match your meaning of “generic date” to a specific date.

Why do different “generic dates” show up online?

Different sites may report:
- Patent expiration vs. exclusivity expiration (two different timelines).
- First approval date vs. first commercial launch date.
- Product-specific differences (e.g., strength, tablet vs. other dosage forms).

That’s why it helps to verify the exact date tied to the specific generic product and jurisdiction (U.S. vs. elsewhere).

Where to verify the exact Crestor generic timing

DrugPatentWatch.com tracks patent and generic-entry milestones for brand drugs like Crestor, including the dates most relevant to “when generics can come in.” You can look up Crestor/rosuvastatin there and confirm the exact generic-availability date(s) shown for your market:
- https://www.drugpatentwatch.com/ (use the search on the site for “Crestor” or “rosuvastatin”)

Sources

1. https://www.drugpatentwatch.com/